Tsaganos, T., Raftogiannis, M., Pratikaki, M., Christodoulou, S., Kotanidou, A., Papadomichelakis, E., . . . Giamarellos-Bourboulis, E. J. (2016). Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and Sepsis. Antimicrob Agents Chemother.
Stile di citazione ChicagoTsaganos, Thomas, Maria Raftogiannis, Maria Pratikaki, Sofia Christodoulou, Anastasia Kotanidou, Evangelos Papadomichelakis, Apostolos Armaganidis, Christina Routsi, e Evangelos J. Giamarellos-Bourboulis. "Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and Sepsis." Antimicrob Agents Chemother 2016.
Citazione MLATsaganos, Thomas, et al. "Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and Sepsis." Antimicrob Agents Chemother 2016.